These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 3321102)

  • 1. Metabolism and reactions of quinoid anticancer agents.
    Powis G
    Pharmacol Ther; 1987; 35(1-2):57-162. PubMed ID: 3321102
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of products of quinoid metabolism of adrenaline on the development of malignant tumors].
    Arsiriĭ SA
    Patol Fiziol Eksp Ter; 1971; 15(4):77-9. PubMed ID: 5148133
    [No Abstract]   [Full Text] [Related]  

  • 3. Are reduced quinones necessarily involved in the antitumour activity of quinone drugs?
    Butler J; Hoey BM
    Br J Cancer Suppl; 1987 Jun; 8():53-9. PubMed ID: 3307874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Free radical formation by antitumor quinones.
    Powis G
    Free Radic Biol Med; 1989; 6(1):63-101. PubMed ID: 2492250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural and synthetic quinones and their reduction by the quinone reductase enzyme NQO1: from synthetic organic chemistry to compounds with anticancer potential.
    Colucci MA; Moody CJ; Couch GD
    Org Biomol Chem; 2008 Feb; 6(4):637-56. PubMed ID: 18264564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indolequinone antitumor agents: relationship between quinone structure and rate of metabolism by recombinant human NQO1.
    Beall HD; Hudnott AR; Winski S; Siegel D; Swann E; Ross D; Moody CJ
    Bioorg Med Chem Lett; 1998 Mar; 8(5):545-8. PubMed ID: 9871615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redox and addition chemistry of quinoid compounds and its biological implications.
    Brunmark A; Cadenas E
    Free Radic Biol Med; 1989; 7(4):435-77. PubMed ID: 2691341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel quinolinequinone antitumor agents: structure-metabolism studies with NAD(P)H:quinone oxidoreductase (NQO1).
    Fryatt T; Pettersson HI; Gardipee WT; Bray KC; Green SJ; Slawin AM; Beall HD; Moody CJ
    Bioorg Med Chem; 2004 Apr; 12(7):1667-87. PubMed ID: 15028260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of NAD(P)H oxidoreductase (DT-Diaphorase) in the bioactivation of quinone-containing antitumor agents: a review.
    Gutierrez PL
    Free Radic Biol Med; 2000 Aug; 29(3-4):263-75. PubMed ID: 11035255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electron paramagnetic resonance study of the generation of reactive oxygen species catalysed by transition metals and quinoid redox cycling by inhalable ambient particulate matter.
    Valavanidis A; Fiotakis K; Bakeas E; Vlahogianni T
    Redox Rep; 2005; 10(1):37-51. PubMed ID: 15829110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indolequinone antitumor agents: correlation between quinone structure, rate of metabolism by recombinant human NAD(P)H:quinone oxidoreductase, and in vitro cytotoxicity.
    Beall HD; Winski S; Swann E; Hudnott AR; Cotterill AS; O'Sullivan N; Green SJ; Bien R; Siegel D; Ross D; Moody CJ
    J Med Chem; 1998 Nov; 41(24):4755-66. PubMed ID: 9822546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and Intracellular Redox Cycling of Natural Quinones and Their Analogues and Identification of Indoleamine-2,3-dioxygenase (IDO) as Potential Target for Anticancer Activity.
    Blunt CE; Torcuk C; Liu Y; Lewis W; Siegel D; Ross D; Moody CJ
    Angew Chem Int Ed Engl; 2015 Jul; 54(30):8740-5. PubMed ID: 26096359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotinamide adenine dinucleotide (phosphate): quinone oxidoreductase (DT-diaphorase) as a target for bioreductive antitumor quinones: quinone cytotoxicity and selectivity in human lung and breast cancer cell lines.
    Beall HD; Murphy AM; Siegel D; Hargreaves RH; Butler J; Ross D
    Mol Pharmacol; 1995 Sep; 48(3):499-504. PubMed ID: 7565631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quinoid secretions in grain and flour beetles.
    Ladisch RK; Ladisch SK; Howe PM
    Nature; 1967 Aug; 215(5104):939-40. PubMed ID: 6055420
    [No Abstract]   [Full Text] [Related]  

  • 15. Enzyme-directed bioreductive drug development revisited: a commentary on recent progress and future prospects with emphasis on quinone anticancer agents and quinone metabolizing enzymes, particularly DT-diaphorase.
    Workman P
    Oncol Res; 1994; 6(10-11):461-75. PubMed ID: 7620214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. omicron-Quinone formation in the biochemical oxidation of the antitumor drug N2-methyl-9-hydroxyellipticinium acetate.
    Bernadou J; Meunier G; Paoletti C; Meunier B
    J Med Chem; 1983 Apr; 26(4):574-9. PubMed ID: 6834391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of antiviral and antitumor photoactive drug hypocrellin A with human serum albumin.
    Kocisová E; Jancura D; Sánchez-Cortés S; Miskovský P; Chinsky L; García-Ramos JV
    J Biomol Struct Dyn; 1999 Aug; 17(1):111-20. PubMed ID: 10496426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quinones as mutagens, carcinogens, and anticancer agents: introduction and overview.
    Smith MT
    J Toxicol Environ Health; 1985; 16(5):665-72. PubMed ID: 4093988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Redox cycling of potential antitumor aziridinyl quinones.
    Lusthof KJ; de Mol NJ; Richter W; Janssen LH; Butler J; Hoey BM; Verboom W; Reinhoudt DN
    Free Radic Biol Med; 1992 Dec; 13(6):599-608. PubMed ID: 1334033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NRH:quinone oxidoreductase 2 (NQO2) catalyzes metabolic activation of quinones and anti-tumor drugs.
    Celli CM; Tran N; Knox R; Jaiswal AK
    Biochem Pharmacol; 2006 Jul; 72(3):366-76. PubMed ID: 16765324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.